Jacobs Levy Equity Management Inc. Purchases Shares of 21,784 Ardent Health Partners, LLC (NYSE:ARDT)

Jacobs Levy Equity Management Inc. purchased a new stake in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 21,784 shares of the company's stock, valued at approximately $372,000.

Several other hedge funds have also modified their holdings of the stock. US Bancorp DE bought a new position in Ardent Health Partners in the fourth quarter valued at approximately $31,000. R Squared Ltd bought a new position in Ardent Health Partners in the fourth quarter valued at approximately $37,000. New York State Common Retirement Fund bought a new position in Ardent Health Partners in the fourth quarter valued at approximately $48,000. Deutsche Bank AG boosted its stake in Ardent Health Partners by 1,251.9% in the fourth quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock valued at $49,000 after acquiring an additional 2,654 shares during the last quarter. Finally, JPMorgan Chase & Co. bought a new position in Ardent Health Partners in the third quarter valued at approximately $154,000.

Ardent Health Partners Stock Down 1.3%

ARDT stock traded down $0.19 during trading hours on Friday, reaching $14.61. 280,957 shares of the stock were exchanged, compared to its average volume of 393,743. The firm's 50-day moving average is $13.24 and its 200-day moving average is $14.76. The company has a market cap of $2.09 billion and a price-to-earnings ratio of 8.96. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. Ardent Health Partners, LLC has a 12 month low of $11.31 and a 12 month high of $20.72.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.21 by $0.08. The firm had revenue of $1.50 billion for the quarter, compared to the consensus estimate of $1.50 billion. On average, equities research analysts expect that Ardent Health Partners, LLC will post 1.23 earnings per share for the current year.

Analyst Upgrades and Downgrades

ARDT has been the topic of a number of recent research reports. Mizuho reduced their price objective on shares of Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Royal Bank of Canada restated an "outperform" rating and issued a $21.00 price objective on shares of Ardent Health Partners in a research report on Thursday, May 15th. Stephens restated an "overweight" rating and issued a $21.00 price objective on shares of Ardent Health Partners in a research report on Tuesday. Finally, Guggenheim upped their price objective on shares of Ardent Health Partners from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Friday, May 9th. Two research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Buy" and a consensus target price of $20.67.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.